메뉴 건너뛰기




Volumn 25, Issue 4, 2001, Pages 353-357

Donor lymphocyte infusion followed by interferon-α plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

Author keywords

Allogeneic bone marrow transplantation; Cellular chimerism; Chronic myelogenous leukemia; Donor lymphocyte infusion; Genetic monitoring; Interferon ; Leukemia relapse; Minimal residual disease

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; LEUKOCYTE ANTIGEN; METHOTREXATE;

EID: 0035127558     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00143-0     Document Type: Article
Times cited : (9)

References (10)
  • 4
    • 0006098664 scopus 로고    scopus 로고
    • Jólkowska J, Wachowiak J, Lange A, Kwissa M, Witt M. Molecular assessment of post-BMT chimerism with the use of various biological specimens and automated DNA sizing technology. J Hematother, in press.
  • 5
    • 0008361676 scopus 로고
    • G-CSF stimulated donor peripheral blood infusions as immunotherapy in patients with haematologic malignancies relapsing after allogeneic transplantation
    • abstract
    • (1995) Blood , vol.86
    • Flowers, M.E.D.1    Sullivan, K.M.2    Martin, P.3
  • 6
    • 4243907253 scopus 로고    scopus 로고
    • Management of relapse
    • Apperley J., Gluckman E., Gratwohl A. (Eds.), Blood and marrow transplantation, ESH-EBMT
    • (1998) , pp. 169-180
    • Kolb, H.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.